Literature DB >> 25026397

Both JNK and P38 MAPK pathways participate in the protection by dexmedetomidine against isoflurane-induced neuroapoptosis in the hippocampus of neonatal rats.

Zhaoxia Liao1, Dexiong Cao2, Xue Han3, Chuiliang Liu4, Jun Peng5, Zhiyi Zuo6, Fei Wang7, Yujuan Li8.   

Abstract

Dexmedetomidine, a highly selective α2-adrenergic agonist, has been reported to attenuate isoflurane-induced cognitive impairment and neuroapoptosis. However, the underlying molecular mechanisms remain poorly understood. The aim of this study was to investigate whether mitogen-activated protein kinase (MAPK) pathway was involved in dexmedetomidine-induced neuroprotection against isoflurane effects. Seven-day-old (P7) neonatal Sprague-Dawley rats were pretreated with various concentrations of dexmedetomidine, and then exposed to 0.75% isoflurane or air for 6h. Terminal deoxyribonucleotide transferase-mediated dUTP nick end labeling (TUNEL) was used to detect neuronal apoptosis in their hippocampus. Activated caspase-3, extracellular signal-regulated kinase 1/2 (ERK1/2), c-Jun NH2-terminal kinases (JNK), p38, phospho-ERK1/2, phospho-JNK and phospho-p38 proteins were detected by Western blotting in the hippocampus at the end of exposure. Also, P7 rats were pretreated with 75 μg/kg dexmedetomidine alone, or given the ERK inhibitor U0126 before dexmedetomidine pretreatment, or pretreated with the p38 MAPK inhibitor SB203580 or JNK inhibitor SP600125 alone, and then exposed to 0.75% isoflurane for 6h. Isoflurane induced significant neuroapoptosis, increased the protein expression of phospho-JNK, phospho-c-Jun, phospho-p38 and phospho-nuclear factor-κB (NF-κB), decreased the level of phospho-ERK1/2 protein and reduced the ratio of Bcl-2/Bax in the hippocampus. Dexmedetomidine pretreatment inhibited isoflurane-induced neuroapoptosis and restored proteins expression of MAPK pathways and the Bcl-2/Bax ratio after isoflurane exposure. Moreover, SB203580 and SP600125 also partly attenuated the isoflurane-induced protein changes. However, U0126 did not reverse dexmedetomidine-induced neuroprotection. Our results indicate that the JNK and p38 pathways, not the ERK pathway are involved in dexmedetomidine-induced neuroprotection against isoflurane effects.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Apoptosis; Caspase-3; Dexmedetomidine; Isoflurane; Mitogen-activated protein kinase (MAPK)

Mesh:

Substances:

Year:  2014        PMID: 25026397     DOI: 10.1016/j.brainresbull.2014.07.001

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  27 in total

1.  Influence of sevoflurane exposure on mitogen-activated protein kinases and Akt/GSK-3β/CRMP-2 signaling pathways in the developing rat brain.

Authors:  Yafang Liu; Chuiliang Liu; Minting Zeng; Xue Han; Kun Zhang; Yanni Fu; Jue Li; Yujuan Li
Journal:  Exp Ther Med       Date:  2017-12-18       Impact factor: 2.447

2.  [Effect of ulinastatin on isoflurane-induced neuronal apoptosis in the hippocampus of rats].

Authors:  Yuanbo Guo; Yan Wang; Dengwen Zhang; Can Cui; Tao Li; Sheng Wang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-07-30

3.  Neuroprotective Effects of Dexmedetomidine Against Hypoxia-Induced Nervous System Injury are Related to Inhibition of NF-κB/COX-2 Pathways.

Authors:  Wanying Pan; Lin Lin; Nan Zhang; Fuli Yuan; Xiaoxiao Hua; Yueting Wang; Liqiu Mo
Journal:  Cell Mol Neurobiol       Date:  2015-12-18       Impact factor: 5.046

Review 4.  Early Life Stress and Epigenetics in Late-onset Alzheimer's Dementia: A Systematic Review.

Authors:  Erwin Lemche
Journal:  Curr Genomics       Date:  2018-11       Impact factor: 2.236

Review 5.  Assessing and conveying risks and benefits of imaging in neonates using ionizing radiation and sedation/anesthesia.

Authors:  Gary R Schooler; Joseph P Cravero; Michael J Callahan
Journal:  Pediatr Radiol       Date:  2021-07-20

Review 6.  Dexmedetomidine May Produce Extra Protective Effects on Sepsis-induced Diaphragm Injury.

Authors:  Jin Wu; Shi-Tong Li
Journal:  Chin Med J (Engl)       Date:  2015-05-20       Impact factor: 2.628

7.  Dexmedetomidine Modulates Histamine-induced Ca(2+) Signaling and Pro-inflammatory Cytokine Expression.

Authors:  Dongki Yang; Jeong Hee Hong
Journal:  Korean J Physiol Pharmacol       Date:  2015-08-20       Impact factor: 2.016

8.  Dexmedetomidine attenuates repeated propofol exposure-induced hippocampal apoptosis, PI3K/Akt/Gsk-3β signaling disruption, and juvenile cognitive deficits in neonatal rats.

Authors:  Yujie Wang; Changyi Wu; Bin Han; Fei Xu; Mingfeng Mao; Xiangyang Guo; Jun Wang
Journal:  Mol Med Rep       Date:  2016-05-23       Impact factor: 2.952

Review 9.  Propofol-Induced Neurotoxicity in the Fetal Animal Brain and Developments in Modifying These Effects-An Updated Review of Propofol Fetal Exposure in Laboratory Animal Studies.

Authors:  Ming Xiong; Li Zhang; Jing Li; Jean Eloy; Jiang Hong Ye; Alex Bekker
Journal:  Brain Sci       Date:  2016-03-28

10.  Dexmedetomidine post-conditioning attenuates cerebral ischemia following asphyxia cardiac arrest through down-regulation of apoptosis and neuroinflammation in rats.

Authors:  Guangqian Li; Pan Gu; Dan Fan
Journal:  BMC Anesthesiol       Date:  2021-06-28       Impact factor: 2.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.